ProVation MD Tapped by Olympus as Recommended EndoWorks Replacement

Tuesday, June 30, 2015

MINNEAPOLIS--(BUSINESS WIRE)--
Wolters
Kluwer, a leading global provider of information and point of
care solutions for the healthcare industry, announced today that its
ProVation® MD software for structured
gastroenterology procedure documentation and coding has been named by
Olympus as one of its recommended replacements for EndoWorks, which is
being retired. As a preferred replacement vendor, Wolters Kluwer worked
directly with Olympus on a methodology to seamlessly migrate data from
EndoWorks to ProVation® MD with minimal impact
on clinician time and productivity.

To aid customers impacted by its decision to exit the endowriter market,
Olympus has identified ProVation
MD and one other software solution as recommended replacements for
EndoWorks, which will be phased out over three years. Olympus developed
a data export utility specifically to streamline migration of historical
data from EndoWorks to the replacement solution. This was made available
for licensing to only Wolters Kluwer and the second Olympus-recommended
vendor. That is a crucial distinction, as the utility is based on
Olympus specifications to enable a more robust and comprehensive
transition that is transparent to end users and requires limited
assistance from the customer's IT staff.

“In selecting ProVation MD, Olympus recognized that our 20 years as a
leader in GI documentation and extensive experience in managing clinical
data would significantly benefit the hospitals, surgery centers and GI
practices that seek a smooth transition for their endowriter software,”
said David Del Toro, Vice President and General Manager, Clinical
Documentation, Wolters Kluwer Health, Clinical Solutions. “Wolters
Kluwer has worked closely with Olympus to develop a staged data
migration methodology available only to the two Olympus-selected
vendors. Along with a smooth, disruption-free migration to ProVation MD,
we provide unparalleled end user training and world-class customer
service throughout the transition to ensure maximum adoption and
clinical efficiency.”

About Wolters KluwerWolters
Kluwer is a global leader in professional information services.
Professionals in the areas of legal, business, tax, accounting, finance,
audit, risk, compliance and healthcare rely on Wolters Kluwer’s market
leading information-enabled tools and software solutions to manage their
business efficiently, deliver results to their clients, and succeed in
an ever more dynamic world.

Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group
serves customers in over 170 countries, and employs over 19,000 people
worldwide. The company is headquartered in Alphen aan den Rijn, the
Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam
(WKL) and are included in the AEX and Euronext 100 indices. Wolters
Kluwer has a sponsored Level 1 American Depositary Receipt program. The
ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

About Olympus Medical Systems GroupOlympus
Medical Systems Group, a division of global technology leader
Olympus, develops solutions for healthcare professionals that help
improve clinical outcomes, reduce overall costs and enhance quality of
life for their patients. By enabling less invasive procedures,
innovative diagnostic and therapeutic endoscopy, and early stage lung
cancer evaluation and treatments, Olympus is transforming the future of
healthcare.